en English

Human Development

Mar 2, 2026

Christopher Marquis

With a hostile political atmosphere making investors increasingly wary of vaccine-related research in the US, firms are winding down development programs, shelving manufacturing plans, and laying off workers. While these responses are understandable, they are short-sighted.